Mark C. Wiggins's most recent trade in TRACON Pharmaceuticals Inc was a trade of 80,000 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 28, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| TRACON Pharmaceuticals Inc | Mark C. Wiggins | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2022 | 80,000 | 80,000 | - | - | Employee Stock Option (Right to Buy) | |
| TRACON Pharmaceuticals Inc | Mark C. Wiggins | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2021 | 55,000 | 55,000 | - | - | Employee Stock Option (Right to Buy) | |
| TRACON Pharmaceuticals Inc | Mark C. Wiggins | Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 10.57 per share. | 29 Dec 2020 | 997 | 13,697 (0%) | 0% | 10.6 | 10,538 | Common Stock |
| TRACON Pharmaceuticals Inc | Mark C. Wiggins | Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 10.67 per share. | 29 Dec 2020 | 3 | 13,700 (0%) | 0% | 10.7 | 32 | Common Stock |
| TRACON Pharmaceuticals Inc | Mark C. Wiggins | Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 4.14 per share. | 10 Sep 2020 | 7,000 | 12,350 (0%) | 0% | 4.1 | 28,953 | Common Stock |